Division of Nephrology, Department of Medicine, London Health Sciences Centre, and The University of Western Ontario, London, Ontario, Canada.
Am J Kidney Dis. 2010 Jul;56(1):69-76. doi: 10.1053/j.ajkd.2009.12.037. Epub 2010 Mar 19.
Extracellular fluid expansion is common in hemodialysis patients. Aggressive fluid removal may lead to intradialytic complications. High dialysate sodium concentrations may lessen complications, but may increase extracellular volume. We hypothesized that decreasing plasma sodium concentration during dialysis will increase sodium removal and decrease extracellular volume.
Pilot clinical trial.
SETTING & PARTICIPANTS: 16 patients with end-stage kidney disease treated using thrice-weekly hemodialysis at a university teaching hospital hemodialysis unit.
Stepwise decrease in postdialysis plasma sodium level (calculated as end-of-session plasma conductivity) over 4 phases effected by dialysate conductivity measurement cells and a biofeedback software system (Diacontrol; Hospal, www.hospal.it) that allowed alteration of dialysate inlet conductivity and calculation of plasma conductivity.
Decrease in postdialysis plasma sodium (conductivity) levels, sodium removal, redistribution of body water, and effect of these on interdialytic weight gain and blood pressure.
Plasma sodium and conductivity values (the latter measured in millisiemens per centimeter); ionic mass balance (sodium removal); bioelectrical impedance analysis measurements of body-water compartments and phase angle; interdialytic weight gain; and blood pressure.
Plasma sodium concentrations at the end of dialysis were decreased from 137.8 (phase 1) to 135.6 mmol/L (phase 4) and end-of-session plasma conductivity values were decreased from 14.0 (phase 1) to 13.5 mS/cm (phase 4; all mean values). Ionic mass balance increased from 383 to 480 mmol. Extracellular water was significantly decreased, phase angle was increased, and blood pressure and interdialytic weight gain were decreased. Plasma sodium levels correlated significantly with plasma conductivity; thus, changes in postdialysis plasma sodium levels can be inferred from changes in end-of-session plasma conductivity values.
Small number of patients. No information for dietary sodium intake.
To decrease extracellular volume, it may be necessary to add diffusive to convective sodium losses.
细胞外液扩张在血液透析患者中很常见。积极的液体清除可能会导致透析过程中的并发症。高透析液钠浓度可能会减少并发症,但可能会增加细胞外液量。我们假设在透析过程中降低血浆钠浓度会增加钠的清除并减少细胞外液量。
初步临床试验。
16 名在一所大学教学医院血液透析病房接受每周三次血液透析治疗的终末期肾病患者。
通过透析液电导率测量单元和生物反馈软件系统(Diacontrol;Hospal,www.hospal.it)逐步降低透析后血浆钠水平(计算为透析结束时的血浆电导率),该系统允许改变透析液入口电导率并计算血浆电导率。
透析后血浆钠(电导率)水平、钠清除率、体内水的再分布以及这些因素对透析间期体重增加和血压的影响。
血浆钠和电导率值(后者以毫西门子/厘米表示);离子质量平衡(钠清除率);生物电阻抗分析测量身体水分室和相位角;透析间期体重增加;和血压。
透析结束时的血浆钠浓度从 137.8mmol/L(第 1 阶段)降低到 135.6mmol/L(第 4 阶段),结束时的血浆电导率值从 14.0mS/cm(第 1 阶段)降低到 13.5mS/cm(第 4 阶段;所有平均值)。离子质量平衡从 383mmol 增加到 480mmol。细胞外液明显减少,相位角增加,血压和透析间期体重增加减少。血浆钠水平与血浆电导率显著相关;因此,可以从透析结束时的血浆电导率值的变化推断出透析后血浆钠水平的变化。
患者数量少。没有关于饮食钠摄入量的信息。
为了减少细胞外液量,可能需要增加扩散到对流的钠丢失。